Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

24,729 signal articles · 246 in last 24h · 117,840 total before filter · latest 56m ago
246last 24h
1642last 7d
263● bullish (7d)
155● bearish (7d)
205publishers
AllMacro312Earnings697M&A92Regulatory27Product13Analyst24
✕ clear all filtersticker: NVDASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
SK Hynix Jumps 5%, AMD Rises 4% as Korea Becomes the New Catalyst for Global Chip Stocks
24/7 Wall St.29d agobullish
SK Hynix Jumps 5%, AMD Rises 4% as Korea Becomes the New Catalyst for Global Chip Stocks

Shares of SK Hynix (NASDAQ:SKHY) are up 5% to $161.42 in Monday’s early trading, leading a broad rebound across global chip stocks. Advanced Micro Devices (NASDAQ:AMD) stock is up 3% to $514, Intel (NASDAQ:INTC) stock 2% higher at $97.25, and NVIDIA (NASDAQ:NVDA) stock is up 2% to $206. The bounce follows a brutal stretch for ... SK Hynix Jumps 5%, AMD Rises 4% as Korea Becomes the New Catalyst for Global Chip Stocks

3 Not-So-Obvious AI Stocks to Buy in July
24/7 Wall St.29d agobullish
3 Not-So-Obvious AI Stocks to Buy in July

Everyone already owns NVIDIA, Microsoft, and Alphabet, but the real AI infrastructure buildout is quietly funneling billions into a different layer of the stack. Three under-the-radar names are converting that spending into hard revenue growth right now.

Will GM or 3M Crush Earnings? Wall Street Favors This One
24/7 Wall St.29d agoneutral
Will GM or 3M Crush Earnings? Wall Street Favors This One

GM and 3M both report Q2 2026 earnings Tuesday morning, and both stocks carry four straight quarters of EPS beats. But analyst ratings, sentiment scores, and prediction markets are telling very different stories about which name deserves your attention right now.

Bristol Myers buys Nvidia's latest AI computing system for drug research
Reuters29d agobullish
Bristol Myers buys Nvidia's latest AI computing system for drug research

Bristol Myers Squibb said on Monday it is buying the latest-generation computing system from chip company Nvidia ‌to support its use of artificial intelligence across its drug discovery and development ‌operations. The drugmaker said it will be the first life sciences company to buy an Nvidia DGX SuperPOD ​based on its Vera Rubin systems. The chipmaker unveiled its Vera Rubin architecture earlier this year as the successor to its current generation of AI computing systems.